TWST Twist Bioscience Corp

Price (delayed)

$123.87

Market cap

$6.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.65

Enterprise value

$5.69B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights

TWST's gross profit has surged by 185% year-on-year and by 18% since the previous quarter

TWST's revenue has soared by 72% YoY and by 12% from the previous quarter

Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ

TWST's quick ratio has surged by 78% year-on-year but it is down by 13% since the previous quarter

Sector: Healthcare

Industry: Diagnostics & Research

Website: https://www.twistbioscience.com/

Peers: NVCR NVAX ONVO ORTX

Key stats

What are the main financial stats of TWST

Market

Shares outstanding

48.89M

Market cap

$6.06B

Enterprise value

$5.69B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

9.81

Price to sales (P/S)

53.39

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

50.34

Earnings

Revenue

$113M

EBIT

-$122.42M

EBITDA

-$114.83M

Free cash flow

-$115.25M

Per share

EPS

-$2.65

Free cash flow per share

-$2.37

Book value per share

$12.63

Revenue per share

$2.32

TBVPS

$13.88

Balance sheet

Total assets

$677.29M

Total liabilities

$63.11M

Debt

$31.93M

Equity

$614.18M

Working capital

$567.56M

Liquidity

Debt to equity

0.05

Current ratio

15.03

Quick ratio

14.41

Net debt/EBITDA

3.2

Margins

EBITDA margin

-101.6%

Gross margin

37%

Net margin

-109.2%

Operating margin

-108.8%

Efficiency

Return on assets

-22.6%

Return on equity

-25.5%

Return on invested capital

-43.6%

Return on capital employed

-19.2%

Return on sales

-108.3%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

TWST stock price

How has the Twist Bioscience stock price performed over time

Intraday

2.97%

1 week

4.02%

1 month

-5.71%

1 year

86.41%

YTD

-12.33%

QTD

-7.04%

Financial performance

How have Twist Bioscience's revenue and profit performed over time

Revenue

$113M

Gross profit

$41.77M

Operating income

-$122.96M

Net income

-$123.34M

Gross margin

37%

Net margin

-109.2%

TWST's gross profit has surged by 185% year-on-year and by 18% since the previous quarter

TWST's revenue has soared by 72% YoY and by 12% from the previous quarter

TWST's gross margin has surged by 66% year-on-year and by 6% since the previous quarter

Twist Bioscience's net margin has soared by 51% YoY and by 6% from the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation

P/E

N/A

P/B

9.81

P/S

53.39

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

50.34

TWST's EPS is up by 40% year-on-year and by 2.6% since the previous quarter

Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ

TWST's P/B is 8% above its last 4 quarters average of 8.8

TWST's revenue has soared by 72% YoY and by 12% from the previous quarter

TWST's P/S is 18% above its last 4 quarters average of 44.1

Efficiency

How efficient is Twist Bioscience business performance

The return on equity has surged by 70% year-on-year and by 14% since the previous quarter

The ROA has soared by 65% YoY and by 12% from the previous quarter

Twist Bioscience's ROIC has soared by 60% YoY and by 6% from the previous quarter

TWST's return on sales has surged by 51% year-on-year and by 6% since the previous quarter

Dividends

What is TWST's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time

Twist Bioscience's total assets has surged by 109% YoY but it has decreased by 3.2% QoQ

TWST's quick ratio has surged by 78% year-on-year but it is down by 13% since the previous quarter

Twist Bioscience's debt is 95% less than its equity

Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ

Twist Bioscience's debt to equity has shrunk by 67% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.